Drug Lobby Touts Pfizer's Kickback Challenge At High Court
By Jeff Overley · November 14, 2022, 11:26 PM EST
The pharmaceutical industry's largest lobbying group Monday threw its weight behind Pfizer's attack on federal health-fraud enforcers, warning the U.S. Supreme Court that capacious views of a key kickback law have...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login